Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.

AJNR. American journal of neuroradiology - 1 Jul 2023

Wagner M W, Nobre L, Namdar K, Khalvati F, Tabori U, Hawkins C, Ertl-Wagner B B

Abstract excerpt

BACKGROUND AND PURPOSE: No qualitative imaging feature currently predicts molecular alterations of pediatric low-grade gliomas with high sensitivity or specificity. The T2-FLAIR mismatch sign predicts IDH-mutated 1p19q noncodeleted adult gliomas with high specificity. We aimed to assess the significance of the T2-FLAIR mismatch sign in pediatric low-grade gliomas. MATERIALS AND METHODS: Pretreatment MR images...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Magnetic Resonance Imaging
Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 37348970
DOI: 10.3174/ajnr.A7916
PMCID: PMC10337621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.PMID 37348970Read ↗

MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation of BRAF V600E Mutation, BRAF Fusion, and Wild-Type Tumors in Patients without Neurofibromatosis-1.Semantic proximity Read ↗

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas.Semantic proximity Read ↗

"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.Semantic proximity Read ↗

T2-FLAIR Mismatch: An Imaging Biomarker for Children's MYB/MYBL1-Altered Diffuse Astrocytoma or Angiocentric Glioma.Semantic proximity Read ↗

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.Semantic proximity Read ↗

Pediatric Glial Tumors.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis.Semantic proximity Read ↗

T2-FLAIR mismatch sign: a roadmap of pearls and pitfalls.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.Semantic proximity Read ↗

Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of IDH-mutated gliomas.Semantic proximity Read ↗

Illuminating radiogenomic signatures in pediatric-type diffuse gliomas: insights into molecular, clinical, and imaging correlations. Part II: low-grade groupSemantic proximity Read ↗

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.